Trending Topic

3D rendered Medical Illustration of Male Anatomy - Rectal Cancer.
14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Gabriel Valagni, Nkafu Bechem Ndemazie, Tiago Biachi de Castria

Trifluridine/tipiracil (FTD/TPI) is a novel oral formulation of two drugs with promising results in the treatment of metastatic colorectal cancer (mCRC).1 Trifluridine is a thymidine-based nucleoside analogue that, after intracellular phosphorylation, gets incorporated into DNA, causing DNA dysfunction.2 It was first identified by Callahan et al. in 1996 as an active impurity in the herbicide trifluralin, which […]

Robert Mutter, SABCS 2022: Proton therapy and its potential benefits in the treatment of breast cancer

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Dec 20th 2022

Proton therapy is a form of radiation treatment that can precisely target and deliver high radiation doses to a tumour to kill cancerous cells. In this touchONCOLOGY interview, we speak with Dr Robert Mutter (Mayo Clinic Rochester, MN, United States) to tell us a little about proton therapy and its potential benefits in the treatment of breast cancer.

The abstract entitled ‘Phase II randomized trial of conventional versus hypofractionated post-mastectomy proton radiotherapy’ was presented at San Antonio Breast Cancer Symposium (SABCS), 06–10, December, 2022.

Questions:

  1. Could you tell us a little about proton therapy and its potential benefits in the treatment of breast cancer? (0:14)

Disclosures: Robert Mutter has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Shanice Allen

Filmed as a highlight of SABCS 2022

Access more content on Breast Cancer

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup